Connect
← Return to Imagine a future with no prostate biopsies!
Discussion
Imagine a future with no prostate biopsies!
Prostate Cancer | Last Active: Feb 23 9:40pm | Replies (6)Comment receiving replies
The PSE test is being used more often and that dna test, with 94% accuracy, shows whether one is likely or unlikely to have prostate cancer. Its purpose is to help someone decide whether they should have a biopsy or MRI.
Replies to "The PSE test is being used more often and that dna test, with 94% accuracy, shows..."
@bens1 Thank you…this test is exactly the kind of technology that needs to be more universally adopted, rather than the standard PSA test, by which only 32 of every 100 positive results are subsequently diagnosed with cancer.
I found a recent (June 2025) report that is indicative of the potential of the PSE test to avoid unnecessary biopsies and SAVE enormous amounts of health care money.
https://www.mdpi.com/2072-6694/17/13/2193
“While prostate cancer biopsies play a crucial role in diagnosis and staging, the high false-positive rate associated with PSA testing has led to an estimated 750,000 unnecessary biopsies per year.”
“Among the 187 patients evaluated, predictive modeling showed that up to 79.1% (106/134) of patients could safely defer biopsy based on a low-likelihood EpiSwitch PSE result.”
“PSE has the potential to help avoid up to 593,000 procedures per year, conservatively. At an estimated average cost of USD 2500 per biopsy, including procedural, pathology, and complication-related expenses, this represents a potential annual savings of approximately USD 1.48 billion.”
So a cost savings technology ALREADY exists to prevent having to conduct 600,000 biopsies per year….imagine that!
Connect
@bens1 Absolutely!! Almost double the accuracy of PSA - but I am sure the slow as molasses medical community - and the insurance companies that control it - will be agonizingly late in adopting PSE as the go-to screening test for PCa…another shame on us!
Phil